# Bioequivalence Study to Compare Imeglimin HCl 500 mg Film Coated Tablets Versus Twymeeg Tablets 500 mg

> **NCT07691177** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Imeglimin Hydrochloride Film Coated Tablet
- **DRUG:** TWYMEEG® Tablets

## Key facts

- **NCT ID:** NCT07691177
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-06
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-05-13
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691177, "Bioequivalence Study to Compare Imeglimin HCl 500 mg Film Coated Tablets Versus Twymeeg Tablets 500 mg". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*